Are We Any Closer to Intestinal Gene Therapy in Crohn's Disease?
Judy Cho, MD, discusses an ongoing study on gene therapy trials given the recent successes with sickle cell anemia and how far away we are from intestinal gene therapy in Crohn's disease on a podcast episode. “These studies are involved. They're promising. They're incredibly transformative. And most importantly, the side effects: These were chronic effects. They were able to reduce the complications of those thromboembolic diseases,” she said.
Mount Sinai Study Reveals Genetic and Cellular Mechanisms of Crohn’s Disease
Mar 31, 2021 View All Press ReleasesResearchers Identify Opportunities to Advance Genomic Medicine
Jan 27, 2020 View All Press ReleasesDrug Resistance Signature Discovered in Crohn’s Disease
Aug 29, 2019 View All Press Releases